Utah Medical Prod (UTMD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 12-2014 | 12-2013 | 12-2012 | 12-2011 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 11,843 | 11,378 | 11,406 | 10,169 | 7,414 |
| Depreciation Amortization | 3,147 | 3,356 | 3,195 | 3,266 | 2,773 |
| Income taxes - deferred | -901 | -500 | -1,399 | -600 | -549 |
| Accounts receivable | 137 | -365 | 213 | 675 | 502 |
| Accounts payable and accrued liabilities | -265 | 188 | -216 | 50 | -1,213 |
| Other Working Capital | -366 | 1,071 | -938 | 476 | 1,562 |
| Other Operating Activity | 206 | 259 | 47 | -473 | 876 |
| Operating Cash Flow | $13,801 | $15,387 | $12,308 | $13,563 | $11,365 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -176 | -1,110 | -339 | -254 | -247 |
| Net Acquisitions | N/A | N/A | N/A | N/A | -41,084 |
| Purchase Of Investment | N/A | N/A | N/A | N/A | -500 |
| Sale Of Investment | N/A | N/A | N/A | 47 | 15,155 |
| Purchase Sale Intangibles | -70 | -22 | -5 | -1 | -10 |
| Other Investing Activity | -70 | -22 | -5 | -1 | -9 |
| Investing Cash Flow | $-246 | $-1,132 | $-344 | $-208 | $-26,685 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | N/A | N/A | N/A | 26,934 |
| Debt Repayment | -4,777 | -4,035 | -3,908 | -9,093 | -5,942 |
| Common Stock Issued | 343 | 491 | 787 | 1,803 | 485 |
| Common Stock Repurchased | -683 | -1,055 | N/A | -504 | 0 |
| Dividend Paid | -3,846 | -3,765 | -3,675 | -3,555 | -3,433 |
| Other Financing Activity | 72 | 103 | 196 | 178 | 34 |
| Financing Cash Flow | $-8,891 | $-8,261 | $-6,600 | $-11,171 | $18,078 |
| Exchange Rate Effect | -660 | -1,115 | 160 | 153 | -41 |
| Beginning Cash Position | 19,274 | 14,395 | 8,871 | 6,534 | 3,818 |
| End Cash Position | 23,278 | 19,274 | 14,395 | 8,871 | 6,534 |
| Net Cash Flow | $4,004 | $4,879 | $5,524 | $2,337 | $2,717 |
| Free Cash Flow | |||||
| Operating Cash Flow | 13,801 | 15,387 | 12,308 | 13,563 | 11,365 |
| Capital Expenditure | -176 | -1,110 | -339 | -254 | -247 |
| Free Cash Flow | 13,625 | 14,277 | 11,969 | 13,309 | 11,118 |